𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Arterial infusion therapy with low-dose cisplatin and continuous 5-fluorouracil for isolated hepatic recurrence of gastric carcinoma

✍ Scribed by Y. Akamo; H. Takeyama; N. Mohri; F. Teranishi; T. Manabe

Publisher
Springer
Year
2000
Tongue
English
Weight
591 KB
Volume
5
Category
Article
ISSN
1341-9625

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Continuous infusion of 5-fluorouracil an
Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma
✍ Yong-Suk Chung; Yoshito Yamashita; Tohru Inoue; Tasuku Matsuoka; Bunzo Nakata; N πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 3 views

City Uni-11 cases, for an overall response rate of 50%. Patients with good performance versity Medical School, Osaka, Japan. status (PS) (0-1) and differentiated histologic type showed higher response rates (50.0% and 63.6%, respectively) than patients with poor PS (2 or 3) and undifferenti-2 Insti

Repetitive short-course hepatic arterial
Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma
✍ Jun Yong Park; Sang Hoon Ahn; Young Joon Yoon; Ja Kyung Kim; Hyun Woong Lee; Do πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 155 KB

## Abstract ## BACKGROUND. Hepatic arterial infusion chemotherapy (HAIC) has often been selected as a therapeutic option for patients with advanced hepatocellular carcinoma (HCC). The objective of the current study was to evaluate the efficacy and safety of repetitive HAIC with high‐dose 5‐fluorou

Palliative treatment with low-dose conti
Palliative treatment with low-dose continuous infusion 5-fluorouracil in recurrent and/or metastatic undifferentiated nasopharyngeal carcinoma type
✍ Abderrahim Fandi; Abdelkrim Taamma; Nacer Azli; Mounir Bachouchi; Bashar Yanes; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 59 KB πŸ‘ 2 views

## Background: Low-dose protracted continuous infusion (ci) 5-fluorouracil (5-fu), as proposed by lokich et al, has been reported to be active and well tolerated in colorectal and breast cancers. we initiated a phase ii trial with ci 5-fu in heavily pretreated undifferentiated carcinoma of the naso